Diabetic cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Confirmed diagnosis of diabetes mellitus: diagnosed as diabetic in conjunction with the 2024 ADA Standards for the Medical Management of Diabetes Mellitus; 2) Diagnosis of diastolic dysfunction: combined with the 2023 European Heart Association Heart Failure Guidelines, diastolic dysfunction was diagnosed according to echocardiography; 3) Diagnostic criteria for diabetic cardiomyopathy: there is no relevant diagnostic gold standard, combined with the definition of diabetic cardiomyopathy and related literature, mainly based on exclusionary diagnosis, i.e., diabetic patients with clear evidence of cardiac insufficiency, except for hypertension, coronary heart disease, cardiac insufficiency due to heart valve disease; 4) All of the above patients met the age >18 years old adults with complete medical records.
Exclusion criteria
Exclusion criteria: 1. Patients with evidence of previous myocardial infarction, valves, or congenital heart disease; 2. Other patients with mental system diseases and consciousness dysfunction; 3. Patients with severe hepatic and renal insufficiency; 4. Malignant tumors, autoimmune deficiencies; 5. Hematologic diseases; 6. Patients who refuse this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| plasma ELABELA values; B-type Natriuretic Peptide (BNP); | — |
Secondary
| Measure | Time frame |
|---|---|
| interleukin 6 value; | — |
Countries
China
Contacts
Fuxing Hospital of Capital Medical University